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Summary 
Neospora caninum, a tissue-cyst-forming parasite, is the causative agent of bovine neosporosis. It is 
considered to be one of the most important transmissible causes of reproductive failure in cattle; 
abortion and neonatal mortality result in significant economic losses within the cattle industry 
worldwide. The balance between acute (mediated by the tachyzoite stage) and persistent (mediated by 
the bradyzoite stage) phases of the infection is influenced by the immune-status of the animal, and for 
pregnant cows (the intermediate host) is critical for transplacental (vertical) transmission of the parasite 
and associated disease outcomes. The horizontal route from the definitive host, the dog, occurs via 
oocyst ingestion (with sporozoites within) and plays a minor but important role in transmission of the 
infection in cattle. Despite the importance of this disease, there is no vaccine or treatment currently 
available, and the only available control measure to reduce the impact of disease is informed 
management on the farm. The development of vaccines, targeting key biological processes such as 
invasion and persistent infection, is an urgently needed aid in the control of this widespread parasite.    
Keywords: Neospora caninum, bovine neosporosis, transplacental transmission, vaccine candidates 
 
 
 
 
 
Introduction 
Neospora caninum is a protozoan parasite which belongs to the Apicomplexa phylum (Fig.1) and is the 
aetiological agent of bovine neosporosis. This disease causes reproductive failure in cattle and is 
considered to be one of the main causes of infectious abortion with a consequent significant economic 
impact on both the dairy industry and the meat sector. 
Life cycle 
Neospora caninum has a facultative heteroxenous life cycle involving a definitive (some canids e.g. 
dog, coyote and dingo) and certain intermediate hosts (e.g. cattle, sheep, horse, pig, and deer) for the 
development of sexual (definitive hosts) and asexual (definitive and intermediate hosts) stages of the 
parasite.  
Tachyzoite, bradyzoite and sporozite stages (Table 1), contain the basic structures and organelles of 
eukaryotic cells; in addition they have components which are specific for the Apicomplexa phylum: 
conoid, inner membrane complex, apicoplast, micronemes, rhoptries and dense granules (Fig.2). The 
fast replicating tachyzoites disseminate within the host and are responsible for the acute phase of the 
infection. The bradyzoites, residing within tissue cysts replicate slowly and are responsible for the 
persistence of the parasite in cattle. The sporozoites are contained within the oocyst which is the 
structure responsible for parasite survival in the environment and for horizontal transmission between 
definitive host and intermediate hosts. Kul and colleagues have recently described enteroepithelial 
stages that give rise to sporozoites in the definitive host (schizogony, gametogeny and zygote 
formation) in naturally infected dogs. 
The definitive host sheds unsporulated oocysts that then undergo sporogony to become infective 
(Fig.3). When ingested by an intermediate host the sporozoites will be released and transform into 
tachyzoites which are able to proliferate and disseminate to different organs. This phase will end once 
the host develops a protective immune-response, causing transformation of tachyzoites into the more 
slowly proliferating bradyzoites which develop within the tissue cyst, generally confined to nervous 
tissue and skeletal muscle, to establish the persistent phase of infection.  
Transmission 
Transmission in cattle can occur in two ways: horizontally by the ingestion of oocysts or vertically via 
the placenta (transplacental transmission) in pregnant cows (Fig.4). Transplacental transmission can be 
classified depending on the origin of the infection as endogenous (EnTT) or exogenous (ExTT). EnTT 
is caused by the reactivation of tissue cysts in a previously (persistently) infected animal and is 
associated with an endemic pattern of reproductive failure and maintenance of infection within the herd. 
In contrast, ExTT occurs following a primary horizontal infection (oocysts are ingested by a pregnant 
animal) and is associated with an epidemic pattern of abortion. Transmission to the definitive host 
mainly occurs following ingestion of foetal or placental tissues infected with tissue cysts. Infections by 
N. caninum have also been detected in wild animals, evidencing the ability of the parasite to circulate 
between domestic and wild animals.  
Pathogenesis 
A natural infection with N. caninum is asymptomatic in adult animals and the only clinical sign is 
abortion in pregnant cows and neurological signs in infected calves. The main factors influencing the 
pathogenesis of the disease are related to parasite invasion, replication and establishment within the 
host cell (intraspecific variation between isolates has shown different presentations and severity of the 
disease) and the ability of the host to mount an efficient immune-response to inhibit parasite 
proliferation and persistence. 
As a consequence of Neospora infection the host develops a complex immune-response against the the 
parasite. The intracellular location of N. caninum promotes a cell-mediated immune-response (Th1) 
critical for protection against the disease and characterised by the production of pro-inflammatory 
cytokines (e.g. IFN-γ). At mid-gestation a down-regulation of cell mediated immunity occurs to avoid 
foetal rejection. This situation causes a variation in Th1/Th2 balance which can permit a reactivation of 
quiescent bradyzoites to differentiate into tachyzoites and allow dissemination of the parasite to the 
placenta and the foetus. This Th1/Th2 imbalance also makes pregnant cows more susceptible than non-
pregnant animals to a primary infection (horizontal) with Neospora. 
With neosporosis the clinical outcome is related to the period of the pregnancy in which the primary 
infection or reactivation occurs. Foetal immune-competency is not apparent until the first third of the 
pregnancy is completed; as a consequence, the foetus is especially vulnerable in this initial period, and 
death and reabsorption are frequent in cases of infection by N. caninum. The highest rate of abortion 
and transplacental transmission leading to congenitally infected calves with clinical signs occurs in the 
second third of pregnancy, when the foetal immune system is still inchoate. If the infection takes place 
in the last third, the foetus is capable of survival, however, transplacental transmission is highly 
probable leading to healthy calves that are congenitally infected, and may contribute to the prevalence 
of Neospora if retained as breeding stock on the farm. 
Pathological findings and clinical signs 
Abortion can occur as a consequence of different factors affecting the foetus and/or the placenta: a) 
parasite proliferation damaging essential foetal tissues or the placenta, b) insufficient oxygenation or 
nutrition of the foetus due to placental damage, c) release of maternal prostaglandins causing luteolysis 
and therefore abortion, d) alteration of placental immunity associated with the release of maternal pro-
inflammatory cytokines which can cause rejection of the foetus. 
Foetuses lost in early pregnancy are frequently autolysed and the infected placenta often presents with 
multifocal necrotic foci within the cotyledons combined with intact intercotyledonary areas. The 
necrotic foci normally show areas of intense inflammatory infiltration by mononuclear cells and 
dystrophic calcification. These cellular infiltrations begin in the maternal caruncles and then extend to 
the foetal cotyledon, with the appearance of areas of haemorrhage and necrosis. In aborted foetuses and 
stillbirths most commonly lesions are found in the brain (Fig.5) and consist of perivascular cuffs, gliosis 
and distinct multifocal small areas of liquefactive necrosis surrounded by gliosis. Less frequently, 
similar non-suppurative foci of inflammation can also be seen in the heart (Fig.5), liver or rarely in the 
kidney, skeletal muscle or lung. Congenitally infected calves with clinical signs more frequently have 
inflammatory lesions in the spinal cord and less frequently in the brain; hydrocephalus may also be 
present, explaining the ataxia, decreased reflexes and paralysis that may be observed. In calves without 
clinical signs and adult animals, lesions are largely confined to tissue cysts found mainly in the brain 
and less frequency in the heart, liver and muscles. 
Control and vaccination 
In the absence of an effective treatment or vaccine against bovine neosporosis the control of the disease 
relies on management measures on the farm. Control programmes should be adapted to the specific 
situation, for which serological diagnosis is essential for identifying the extent of infection in the herd 
and whether EnTT and/or ExTT is occurring. The main control measures to prevent EnTT must focus 
on avoiding the reactivation of bradyzoites in persistently infected animals by maintaining optimal 
biosecurity and good management to avoid stresses that may favour immunosuppression. Selection of 
seronegative animals for the replacement of breeding stock is another important control measure. The  
risk of ExTT may  be reduced by controlling access of dogs and other potential definitive hosts to the 
farm along with safe disposal of contaminated material (e.g. foetal or placental tissues) and the control 
of other intermediate hosts (e.g. rodents). 
Various drugs and natural extracts have been tested in vitro or in different animal models but their 
efficacy has not been proven in natural infections in cattle. Recently antimalarial drugs and bumped-
kinase inhibitors have been shown to reduce both proliferation in vitro and transplacental transmission 
in pregnant mouse models. 
Currently, the best control option is to develop a vaccine designed to prevent both abortion and 
transplacental transmission. Inactivated or classic subunit vaccines against neosporosis are safe but 
currently do not stimulate a protective immunity; the only commercialised vaccine (Neoguard®), based 
on inactivated tachyzoites, has been withdrawn from the market due to low efficacy and ambiguous 
results. As with ovine toxoplasmosis, for which a live vaccine (based on tachyzoites of the S48 
incomplete strain) is commercially available, live vaccination has delivered the best immune-protection 
to date. In order to avoid safety problems (such as reverting to virulence during pregnancy) low 
virulence isolates with a reduced capacity to persist in the host have been proposed as potential 
candidates; this attenuation can be natural (isolates from asymptomatic animals) or induced by 
subsequent manipulation (temperature sensitive strains, multiple passage in cell culture, gamma 
irradiation or transgenic manipulation). However, so far none have been licensed.  
In this context, new generation vaccines (recombinant proteins, DNA or vectored), safe and easy to 
manufacture, are preferred as the principal line of research in vaccine development. The main concern 
for their development is the pre-selection of candidates that can confer immune-protection. Recently, 
in silico tools are becoming available for the prediction of vaccine candidates, but their successful 
application has not been demonstrated yet. Thus lacking certain candidate predictions, proteins involved 
in the lytic cycle of the tachyzoite (Fig.6) and potentially involved in host cell adhesion/invasion and 
parasitophorous vacuole formation (surface proteins and/or those secreted from micronemes, rhoptries 
or dense granules; Fig.2) have been the most studied for their protective potential. These experimental 
vaccines are designed to block specific processes by triggering an immune-response targeting specific 
proteins involved in vital mechanisms and so preventing parasite proliferation. So far several different 
proteins have been tested showing variable results depending on the expression system, route of 
administration and/or adjuvants used. Hemphill and colleagues have reviewed the different candidates 
tested over the last twenty years. To a lesser extent, proteins of the bradyzoite stage have also been 
studied and tested as vaccines with the aim of targeting persistent infections but with little success to 
date.  
In this scenario of partial success, new approaches are being integrated as are the combination of 
different antigens, use of improved adjuvants and enhancers of the immune response (e.g. fusion to 
TLR-ligands) or combinations of live parasites with new drugs. It is also important to highlight the 
increasing interest for DIVA vaccines (differentiating infected from vaccinated animals) which should 
be taken into account in vaccine development against bovine neosporosis. 
Conclusions 
Transplacental transmission is the principal mechanism in the etiology of bovine neosporosis. 
Endogenous transmission (EnTT) is more likely to occur in cattle that were congenitally infected in 
comparison to those which were infected postnatally (when non-pregnant). This could be due to the 
development of an incomplete immunity following a foetal infection; therefore a better understanding 
of the development of immune-protection in the host at different stages is essential. Curiously, this 
situation is significantly different to that in Toxoplasma gondii, for which EnTT seems to play a minor 
role. Targeting and eliminating the persistent phase of infection at first site would seem to be a useful 
objective in Neospora research. However, most of the chemicals and vaccine candidates tested target 
the acute phase of the infection (tachyzoites) rather than the bradyzoites protected within the tissue cyst. 
Advances in the diagnostic tools for N. caninum have provided a good idea of the global impact of 
neosporosis and helped significantly with its control. Unfortunately this is not always enough and 
vaccination still appears to be the best option for reducing losses. The development of new generation 
vaccines is currently constrained by partially successful trials and a lack of novel candidates in the 
pipeline. Many of the mechanisms involved in the Neospora-host interaction have been inferred from 
T. gondii, but it is now clear that there are significant differences between these two parasites and the 
scientific community needs to further explore the biology of Neospora to identify new potential vaccine 
immunogens. Recent proteomic and transcriptome data and further advances in genetic modification 
technologies should also help the identification these candidates along with novel animal models (e.g. 
other ruminants) and so increase the scope for evaluating potential new formulations.  
Further Reading 
Darwich, L., Li, Y., Serrano-Perez, B., Mur-Novales, R., Garcia-Ispierto, I., Cabezon, O., Lopez-
Gatius, F. and Almeria, S. (2016). Maternal and foetal cytokine production in dams naturally 
and experimentally infected with Neospora caninum on gestation day 110. Res Vet Sci, 107, 
55-61. 
Donahoe, S. L., Lindsay, S. A., Krockenberger, M., Phalen, D. and Slapeta, J. (2015). A review of 
neosporosis and pathologic findings of Neospora caninum infection in wildlife. Int J Parasitol 
Parasites Wildl, 4, 216-238. 
Dubey, J. P., Buxton, D. and Wouda, W. (2006). Pathogenesis of bovine neosporosis. J Comp Pathol, 
134, 267-289. 
Goodswen SJ, Barratt JL, Kennedy PJ, Ellis JT: Improving the gene structure annotation of the 
apicomplexan parasite Neospora caninum fulfils a vital requirement towards an in silico-
derived vaccine. International journal for parasitology 2015, 45(5):305-318. 
Hemphill A, Aguado-Martinez A, Muller J: Approaches for the vaccination and treatment of Neospora 
caninum infections in mice and ruminant models. Parasitology 2016, 143(3):245-259. 
Kul, O., Atmaca, H. T., Anteplioglu, T., Ocal, N. and Canpolat, S. (2015). Neospora caninum: the First 
Demonstration of the Enteroepithelial Stages in the Intestines of a Naturally Infected Dog. J 
Comp Pathol, 153, 9-13. 
Reichel, M. P. and Ellis, J. T. (2009). Neospora caninum--how close are we to development of an 
efficacious vaccine that prevents abortion in cattle? Int J Parasitol, 39, 1173-1187. 
Thilsted, J. P. and Dubey, J. P. (1989). Neosporosis-like abortions in a herd of dairy cattle. J Vet Diagn 
Invest, 1, 205-209. 
Trees, A. J. and Williams, D. J. (2005). Endogenous and exogenous transplacental infection in 
Neospora caninum and Toxoplasma gondii. Trends Parasitol, 21, 558-561. 
Winzer, P., Muller, J., Aguado-Martinez, A., Rahman, M., Balmer, V., Manser, V., Ortega-Mora, L. 
M., Ojo, K. K., Fan, E., Maly, D. J., Van Voorhis, W. C. and Hemphill, A. (2015). In Vitro and 
In Vivo Effects of the Bumped Kinase Inhibitor 1294 in the Related Cyst-Forming 
Apicomplexans Toxoplasma gondii and Neospora caninum. Antimicrob Agents Chemother, 59, 
6361-6374 
Acknowledgments 
The author thanks Laura Polledo and Jorge Gonzalez (Micros Veterinaria) for the micrographs of the 
paraffin sections and David Buxton for his suggestions in the manuscript.  
Conflict of interests 
The author declares that she has no competing interests.  
 
Table 1. Principal characteristics of the invasive stages of Neospora caninum 
Characteristics 
Invasive stage 
Tachyzoite Bradyzoite Sporozoite 
Containing structure 
parasitophorous 
vacuole 
tissue cyst oocyst 
Localization in host different cell types 
nervous tissue and 
skeletal muscle tissue 
intestine 
Structures size / wall 
thickness (µm) 
variable 107 / 4 10-12 / 0.6-0.8 
No. of zoites / 
structure 
2-100 up to 200 8 
Zoite length (µm) 5-7 6-8 6-7 
Zoite width (µm) 1-5 1-2 2 
No. of micronemes ~ 150 ~ 150 indeterminate 
No. of rhoptries 8-18 > 8-18 indeterminate 
No. of dense granules ~ 15 8-10 ~ 15 
Nucleus position central sub-terminal 
central or slightly 
posterior 
Cellular division endodyogeny 
asinchronic 
endodyogeny 
schizogony 
 
 
Figure legends 
Figure 1. Taxonomic classification of Neospora caninum and main characteristics of each 
organizational level 
Figure 2. Principal structures and organelles of Neospora caninum 
Figure 3. Life cycle and stages of Neospora caninum. Sporulated oocysts previously shed by the 
definitive host (dog) are ingested by an intermediate host (cow) where sporozoites differentiate into 
tachyzoites which disseminate to different organs (acute phase of infection). Host immune-response 
causes the transformation of tachyzoites into bradyzoites within tissue cysts (persistent phase of 
infection) which can in turn infect the definitive host following their ingestion.  
Figure 4. Transmission of Neospora caninum. Vertical transmission from the cow to offspring can occur 
by endogenous (EnTT, from persistently infected animals) or exogenous (ExTT, from primary infected 
animals) transplacental transmission. The infection can cause the death of the foetus or calf which can 
in turn potentially infect the definitive host. Congenitally infected calves without clinical signs can 
contribute to the maintenance of infection within the herd as well as having the potential to transmit 
horizontally to other domestic or wild species. 
Figure 5. Light micrographs of histological sections stained with haematoxylin and eosin. A. Brain, at 
the level of the thalamus showing non-suppurative encephalitis with a small focus of necrosis 
surrounded by glial cells. B. Higher magnification of the necrotic focus in A. C. Heart, left myocardium, 
showing a multifocal non-suppurative interstitial inflammatory infiltrate. D. Higher magnification of 
the inflammatory infiltrate in C. The bar indicates the magnification of each image. 
Figure 6. Lytic cycle of Neospora caninum. Tachyzoites interact with the host cell by gliding motility 
mediated by the cytoskeleton to establish an initial contact using the surface proteins and those secreted 
by the micronemes. After reorientation the invasion process starts with the involvement of proteins of 
the micronemes and the neck of the rhoptries. At this point the tachyzoite secretes proteins from the 
bulb of the rhoptries and the dense granules into the nascent parasitophorous vacuole for its formation 
and communication with the host cell. Once intracellular the tachyzoite will divide by endodyogeny to 
eventually cause the lysis of the host cell releasing new tachyzoites and either continuing with the lytic 
cycle; or developing into tissue cysts with bradyzoites (persistent phase) as consequence of an efficient 
immune response. 
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